Cisplatin pk
WebNov 18, 2024 · Individual pharmacokinetics (PK) parameters of Cisplatin were identified using a Bayesian approach. Nephrotoxicity and ototoxicity were considered as typical Cisplatin-related toxicities according to Common Terminology Criteria for Adverse Events (CTCAE) standards.
Cisplatin pk
Did you know?
WebWe aimed to evaluate cisplatin pharmacokinetics (PK) and the exposure to unbound cisplatin in SCLC patients using the informative priors, and assess the relationship between the cisplatin... WebJan 27, 2024 · Fig. 4: Prediction of cisplatin PK and PD parameters using the multi-organ-chip IVIVT system. a, The fluidic coupling path of the bone marrow, liver and kidney chips linked to the AV reservoir in ...
WebAug 20, 2024 · Population pharmacokinetic (PK) models for cisplatin are usually one- or two-compartment models and BSA is typically reported as a significant covariate … WebMar 1, 2024 · Cisplatin (Platinol ®) is a chemotherapeutic agent, first approved by the U.S. Food and Drug Administration (FDA) in 1978 for the treatment of ovarian cancer and finds its use nowadays for the treatment of various types of cancer including cervical cancer, testicular cancer and germ cell tumors [1].
WebDec 31, 2008 · The cisplatin dose was 75 mg/m 2 for all cohorts and the pemetrexed dose was increased in increments of 100 mg/m 2 for subsequent cohorts. Treatment and dose escalation scheme. Pemetrexed and cisplatin were administered on day 1 of a 21-d cycle as i.v. infusions of 10 and 60 min, respectively. WebJan 1, 2009 · We evaluated the toxicity and pharmacokinetics (PK) of higher pemetrexed doses with cisplatin and vitamin supplementation. Experimental design: Folic acid and vitamin B(12) were administered per label recommendations. Results: The maximum tolerated dose was 900 mg/m(2) pemetrexed + 75 mg/m(2) cisplatin.
WebPurpose: Cisplatin and carboplatin are frequently used drugs in the treatment of pediatric hepatoblastoma. Dosing guidelines for these drugs in children requiring peritoneal dialysis are lacking. Here, we describe the case of a 3-year-old boy with pre-existing end-stage renal disease on peritoneal dialysis, requiring treatment with cisplatin and carboplatin for …
WebCisplatin is a chemotherapy drug which is used to treat cancers including: sarcoma, small cell lung cancer, germ cell tumors, lymphoma, and ovarian cancer. While it is often … how to replace a radiator valveWebThe pharmacokinetics of platinum (Pt) and cisplatin (CDDP)-DNA adducts were studied in nude mice after single-dose CDDP treatments. Whole blood, serum, kidney, lever, testis, brain, and tumor were collected at different intervals after injection of … how to replace a rainbird valveWebFurther, cisplatin (CDDP)-resistant FaDu cells displayed stem-like features and higher CD44, ABCB1 and ADAM17 expression. Higher autophagic flux and mitophagy were observed in resistant FaDu cells as compared to parental cells, and inhibition of autophagy led to the decrease in stemness, restoration of mitochondrial proteins and reduced ... northants classic bikes rushden websiteWebFor intraperitoneal therapy, paclitaxel or cisplatin was reconstituted in 2 liters of warmed normal saline and infused as rapidly as possible through an implantable peritoneal catheter.... northants county council dog wardenWebFinally, we discovered that integrin α6β4 preferentially activated DNA-PK, facilitated DNA-PK-p53 and p53-53BP1 complex formation in response to cisplatin and required DNA-PK to enhance ATM, 53BP1 and p53 activation as well as cisplatin sensitivity. In summary, we discovered a novel function of integrin α6β4 in promoting cisplatin ... northants concrete group limitedWebDec 15, 2012 · OSTI.GOV Journal Article: Cisplatin Pharmacokinetics in Nontumoral Pig Liver Treated With Intravenous or Transarterial Hepatic Chemoembolization Cisplatin Pharmacokinetics in Nontumoral Pig Liver Treated With Intravenous or Transarterial Hepatic Chemoembolization Full Record Related Research Abstract northants county faWebMethods: An ancillary pharmacokinetics (PK) exploration was performed in the context of a prospective study investigating circulating-tumour cells vs progression-free survival (PFS). Cetuximab plasma concentrations were analysed according to a population PK model. northants county court